课题基金 / 基金详情

Establishment and characterization of T cell clones from autologous tumor-specific T cells in renal cell carcinoma

Establishment and characterization of T cell clones from autologous tumor-specific T cells in renal cell carcinoma
肾细胞癌自体肿瘤特异性 T 细胞 T 细胞克隆的建立和表征
批准号:
05671333
负责人:
MORITA Tatsuo
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

MORITA Tatsuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The present study was designed to establish and characterize the autologous tumor-specific T cells with the use of interleukin 2 (IL 2) gene-transfected murine renal cell carcinoma (Renca). Production of IL 2 by IL 2 gene-transfected Renca (Renca Neo/IL 2) was confirmed by bioassay with CTLL-2 and by RT-PCR.Histological examination of subcutaneous tumors established in Balb/c mice showed that the extent of lymphocyte infiltration in Renca Neo/IL 2 was more significant than that in Renca Neo. Cytotoxic activity of splenic cells and tumor-infiltrating lymphocytes (TIL) from tumor (Renca Neo/IL 2 or Renca Neo)-bearing Balb/c mice revealed that cytotoxic activity of the cells from Renca Neo/IL 2 was significantly higher than that of Renca Neo but was not autologous tumor specific. In conclusion, Renca Neo/IL 2 induces lymphocyte infiltration in local tumor mass, and is more potent than Renca Neo with regard to inducing cytotoxic lymphocytes with wide target spectrum and high cytotoxic activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of cytidine deaminase as a parameter for anticancer drug sensitivity in the tailor-made therapy
  • 批准号:
    13671673
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2001
  • 负责人:
    MORITA Tatsuo
  • 依托单位:
Heterogeneity of bladder cancer : relation to mutations of oncogenes and antioncogene
  • 批准号:
    08671837
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.41万
  • 财政年份:
    1996
  • 负责人:
    MORITA Tatsuo
  • 依托单位:
海外基金